Items
Search full-text
"D Božić"
-
Characteristics of Coaches in the Function of Achieving SportsResults (2022)
L. Vulin, L. Milićević, D. Božić, Characteristics of Coaches in the Function of Achieving SportsResults, International Journal of Academic Health and Medical Research (IJAHMR), Vol. 6, No. 9, pp. 68 - 71, 2022 -
The effects ofphysical activity on disease and mortality (2021)
M. Zelenović, D. Božić, N. Aksović, G. Iacob, R. Alempijević, B. Bjelica, The effects ofphysical activity on disease and mortality, International journal of sport culture and science, Vol. 9, No. 2, pp. 255 - 267, 2021 -
Teorija grešaka geodetskih mjerenja (2025)
Sanja Tucikešić, Branko Božić, Teorija grešaka geodetskih mjerenja, Univerzitet u Banjoj Luci, Arhitektonsko-građevinsko-geodetski fakultet, 2025 -
Lice i naličje sistemskog eritemskog lupusa (2024)
LJ. Božić, Lice i naličje sistemskog eritemskog lupusa, Medicinski fakultet Banjaluka, 2024 -
Correlation of Clinical features of systemic lupus erythematosus and osteoporosis (2025-04)
I. Ovčina, S. Popović Pejičić, S. Šarić, J. Mrđa, LJ. Božić, Correlation of Clinical features of systemic lupus erythematosus and osteoporosis, Apr, 2025 -
Correlation of body mass index and bone mineral density in menopausal women with type 2 diabetes (2025-04)
S. Popović Pejičić, LJ. Božić, N. Pejičić, I. Ovčina, J. Mrđa, D. Popović, Correlation of body mass index and bone mineral density in menopausal women with type 2 diabetes, Apr, 2025 -
Shoud we think about osteoporosis in psoriatic arthritis (2024)
LJ. Božić, I. Ovčina, J. Mrđa, D. Popović, G. Vrhovac, N. Špirić, Shoud we think about osteoporosis in psoriatic arthritis, 2024 -
Primjena adalimumaba u liječenju refraktorne forme Stilove bolesti odraslih (2024-10)
LJ. Božić, S. Šarić, I. Ovčina, J. Mrđa, Primjena adalimumaba u liječenju refraktorne forme Stilove bolesti odraslih, Oct, 2024 -
Interstitial lung disease in antisynthetase syndrome (2016)
LJ. Božić, Interstitial lung disease in antisynthetase syndrome, SIGNA VITAE, 2016 -
Immunophenotyping and real-time PCR in clinical treatement of RA patients (2024-12)
LJ. Božić, Immunophenotyping and real-time PCR in clinical treatement of RA patients, Journal of Chemical, Biological and Physical sciences, Dec, 2024 -
Odgovor na terapiju Rituximabom kod pacijenata sa reumatoidnim artritisom (2010-09)
LJ. Božić, Odgovor na terapiju Rituximabom kod pacijenata sa reumatoidnim artritisom, ACTA RHEUMATOLOGICA BELGRADENSIA, Sep, 2010 -
Prikaz slučaja: '' Vilonodularni sinovitis zgloba kuka'' (2012-09)
LJ. Božić, Prikaz slučaja: '' Vilonodularni sinovitis zgloba kuka'', ACTA RHEUMATOLOGICA BELGRADENSIA, Sep, 2012 -
Prikaz slučaja: Prikaz slučaja pacijentice sa sistemskim eritemskim lupusom I dijabetes melitusom tip 1’’ (2013-03)
LJ. Božić, Prikaz slučaja: Prikaz slučaja pacijentice sa sistemskim eritemskim lupusom I dijabetes melitusom tip 1’’, ACTA RHEUMATOLOGICA BELGRADENSIA, Mar, 2013 -
Prikaz slučaja: '' Sekundarna hipertrofična osteoartropatija'' (2013-06)
LJ. Božić, Prikaz slučaja: '' Sekundarna hipertrofična osteoartropatija'', INTERNIST, Jun, 2013 -
Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks (2016-09)
LJ. Božić, Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, Sep, 2016 -
Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks (2016-09)
LJ. Božić, Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, Sep, 2016 -
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial (2018-08)
LJ. Božić, Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial, STED Journal, Aug, 2018 -
The importance of renal impairment in systemic sclerosis (2023-06)
LJ. Božić, The importance of renal impairment in systemic sclerosis, ANNALS OF THE RHEUMATIC DISEASES, Jun, 2023 -
The effect of socio-demographic characteristics on the burnout syndrome of nurses in Republic of Srpska during the COVID-19 pandemic (2024-09)
LJ. Božić, The effect of socio-demographic characteristics on the burnout syndrome of nurses in Republic of Srpska during the COVID-19 pandemic, Scripta Medica, Sep, 2024 -
Clinical significance of coagulation factor gene mutations (2024-10)
LJ. Božić, Clinical significance of coagulation factor gene mutations, Medicinski žurnal, Oct, 2024